ADD CONDITION

items per page

Bite and Sting Relief

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2013
Label revision date
January 30, 2018
Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2013
Label revision date
January 30, 2018
Manufacturer
Walgreens
Registration number
part348
NDC root
0363-3190

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

If you're experiencing pain and itching from insect bites, this medication can provide temporary relief. It is specifically designed to help soothe the discomfort associated with these bites, allowing you to feel more comfortable. While the exact mechanism of action isn't detailed, its primary purpose is to alleviate the symptoms you may be facing.

Uses

If you’re dealing with discomfort from insect bites, this medication can help provide temporary relief from both pain and itching. It’s designed specifically to ease the irritation that often comes with these pesky bites, allowing you to feel more comfortable.

Rest assured, there are no concerns regarding teratogenic effects (which means it doesn’t cause birth defects) or nonteratogenic effects associated with this medication. You can use it with confidence for the relief you need.

Dosage and Administration

Before using this medication, make sure to shake the bottle well to ensure the ingredients are properly mixed. If you are an adult or a child aged 2 years and older, you can apply the medication directly to the affected area of your skin. You should do this no more than 3 to 4 times a day for the best results.

If your child is under 2 years old, it’s important to consult with a doctor before using this medication. They can provide guidance on the appropriate use and dosage for younger children. Always follow these instructions carefully to ensure safe and effective treatment.

What to Avoid

It's important to handle this medication with care. You should never puncture or incinerate the container, as it is under pressure and can be dangerous. Additionally, make sure to store it in a cool place, avoiding temperatures above 120°F (49°C) to ensure its safety and effectiveness.

While there are no specific contraindications or concerns about abuse, misuse, or dependence associated with this medication, following these guidelines will help you use it safely. Always prioritize your safety and the proper handling of your medications.

Side Effects

Using this product comes with some important safety considerations. It is flammable, so you should avoid using it while smoking or near any heat or flame.

If your condition worsens, or if your symptoms last more than 7 days or improve only to return within a few days, you should stop using the product and consult your doctor.

Warnings and Precautions

It's important to be aware that this product is flammable, so you should avoid using it while smoking or near any heat or flame. Always keep it out of reach of children, and if it is accidentally ingested, seek professional help or contact a Poison Control Center right away.

You should stop using this product and call your doctor if your condition worsens, if your symptoms last more than 7 days, or if your symptoms improve and then come back within a few days. Taking these precautions can help ensure your safety and well-being.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.

Pregnancy Use

When it comes to using this product during pregnancy, there is no specific information available regarding its safety or potential risks to you or your developing baby. The insert does not indicate whether the product is contraindicated (not recommended) for pregnant individuals, nor does it mention any necessary dosage adjustments or special precautions for use during this time.

As always, it's important to consult with your healthcare provider before using any medication or product while pregnant to ensure the best care for you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there is no information available about whether this product is excreted in breast milk or any potential risks to your infant. This means that, based on current knowledge, you can use this product without concern for its effects on your milk production or your baby’s health.

Pediatric Use

If your child is under 2 years old, it's important to consult a doctor before using this medication. For children aged 2 years and older, you can apply the medication to the affected area, but be sure not to exceed 3 to 4 applications per day. Always follow these guidelines to ensure your child's safety and well-being.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that you receive the safest and most effective treatment based on your individual needs.

Drug Interactions

It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the safety and effectiveness of your product, store it in a cool, dry place, avoiding temperatures above 120°F (49°C). It's important to keep the product out of reach of children to prevent any accidental misuse.

When handling the product, please remember not to puncture or incinerate it, as it contains pressurized contents that could be dangerous if mishandled. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years and older. If your child is under 2 years old, it's important to consult a doctor before use.

FAQ

What is the primary use of this drug?

This drug is used for the temporary relief of pain and itching associated with insect bites.

How should I apply this drug?

For adults and children 2 years of age and older, apply to the affected area no more than 3 to 4 times daily. For children under 2 years of age, ask a doctor.

Are there any precautions I should take when using this drug?

Yes, avoid contact with eyes, do not puncture or incinerate the container, and do not store at temperatures above 120°F.

What should I do if my condition worsens?

Stop use and ask a doctor if your condition worsens or if symptoms last more than 7 days or clear up and occur again within a few days.

Is this drug safe to use during pregnancy?

There are no specific warnings or contraindications regarding the use of this drug during pregnancy.

Can nursing mothers use this drug?

There are no specific warnings or recommendations regarding the use of this product by nursing mothers.

What should I do in case of accidental ingestion?

Keep out of reach of children and seek professional help or contact a Poison Control Center immediately in case of accidental ingestion.

Is this drug flammable?

Yes, this drug is flammable; do not use it while smoking or near heat or flame.

Packaging Info

Below are the non-prescription pack sizes of Bite and Sting Relief (benzocaine - 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Relief.
Details

Drug Information (PDF)

This file contains official product information for Bite and Sting Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No additional specific description details are available.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with insect bites.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The formulation should be shaken well prior to use. For adults and children aged 2 years and older, the recommended application is to the affected area, not exceeding 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in situations where the container may be punctured or incinerated, as the contents are under pressure. Additionally, storage at temperatures exceeding 120°F is contraindicated due to the risk of container failure and potential hazards associated with high temperatures.

Warnings and Precautions

Flammable substances should not be used while smoking or in proximity to heat or open flames. Healthcare professionals must advise patients to exercise caution in environments where ignition sources are present to prevent fire hazards.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate professional medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult a healthcare provider if their condition worsens, if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days. These guidelines are essential for ensuring patient safety and effective management of their health conditions.

No specific emergency medical help instructions or laboratory tests have been provided; however, healthcare professionals should remain vigilant and prepared to address any unforeseen complications that may arise during treatment.

Side Effects

Patients should be aware of the potential for serious adverse reactions associated with the use of this product. It is flammable; therefore, it should not be used while smoking or near heat or flame.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. These guidelines are essential to ensure patient safety and effective management of their condition.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Bite and Sting Relief (benzocaine - 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Relief.
Details

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the medication may be applied to the affected area up to 3 to 4 times daily. Care should be taken to adhere to the recommended application frequency to ensure safety and efficacy.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that no specific information regarding the use of this product during pregnancy is provided in the prescribing information. There are no statements indicating whether the product is contraindicated in pregnancy or any associated risks to the fetus. Additionally, no dosage modifications or special precautions regarding the use of this product during pregnancy are mentioned. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized to ensure patient safety and mitigate potential complications associated with overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek professional medical assistance or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, patients should also stop use and seek medical advice.

When using this product, it is important to avoid contact with the eyes and to use the product only as directed. Patients should be cautioned against puncturing or incinerating the container, as it is under pressure. Furthermore, they should not store the product at temperatures exceeding 120°F to ensure safety and efficacy.

Storage and Handling

The product is supplied in a configuration that ensures safety and efficacy. It is essential to store the product at temperatures not exceeding 120°F to maintain its integrity. The container must remain intact; therefore, it should not be punctured or incinerated, as the contents are under pressure. Additionally, it is crucial to keep the product out of reach of children to prevent accidental exposure.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being 3 to 4 times daily to the affected area. For children under 2 years of age, it is advised to consult a doctor before use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Bite and Sting Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Bite and Sting Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.